Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 7/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | PTP4A1 | Q93096 | 1/20 | 0.48 |
| ▸ | MIF | P14174 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.47 |
| ▸ | USP2 | O75604 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.46 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL508463 | 1.00 | CYP2C9 (0.61) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL167037 | 1.00 | CYP2C9 (0.61) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL11652941 | 0.87 | CYP2C9 (0.47) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL11652946 | 0.87 | CYP2C9 (0.47) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL11106211 | 0.87 | CYP2C9 (0.56) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL31636860 | 0.85 | CYP2C9 (0.61) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL2671868 | 0.85 | CYP2C9 (0.43) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL2671866 | 0.85 | CYP2C9 (0.43) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL4546680 | 0.85 | CYP2C9 (0.61) | CYP2C9ALDH1A1TSHRMAPTKDM4E | |
| SCHEMBL4135128 | 0.85 | CYP2C9 (0.61) | CYP2C9ALDH1A1TSHRMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 828 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118879245-A | Negative electrode binder, negative electrode plate and battery | 深圳好电科技有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118063472-A | Imidazo [3,4-d ] pyrimidine compound and synthetic method and application thereof | 河北大学 | 2024-05-24 | — | — | CN | claimed |
| CN-117976996-A | Battery, preparation method thereof and electricity utilization device | 江苏正力新能电池技术有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117447703-A | Multifunctional group modified silane compound and preparation method thereof, hardening coating and preparation method thereof | 深圳市华星光电半导体显示技术有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115215767-B | Process for preparing 2-cyano-3-ethoxyacrylic acid ethyl ester derivative | 帕潘纳(北京)科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-116693541-A | Synthesis method of 4-chloro-5H-pyrrolo [3,2-D ] pyrimidine | 安徽大学 | 2023-09-05 | — | — | CN | claimed |
| CN-116355144-A | Preparation method of composite functional polycarboxylate superplasticizer | 南京师范大学 | 2023-06-30 | — | — | CN | claimed |
| CN-113185512-B | 5-aminopyrimido [4,5-b ] quinoline compound and preparation method and application thereof | 桂林医学院 | 2023-05-05 | — | — | CN | claimed |
| CN-115215767-A | Process for preparing 2-cyano-3-ethoxy ethyl acrylate derivatives | 帕潘纳(北京)科技有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-111276738-B | Asymmetric solid electrolyte, preparation method thereof and application thereof in high-voltage solid-state battery | 中国科学院化学研究所 | 2021-08-31 | — | — | CN | claimed |
| CN-112062692-A | Preparation method of ethyl ethoxymethylene cyanoacetate | 太仓市茜泾化工有限公司 | 2020-12-11 | — | — | CN | claimed |
| CN-111276738-A | Asymmetric solid electrolyte, preparation method thereof and application thereof in high-voltage solid-state battery | 中国科学院化学研究所 | 2020-06-12 | — | — | CN | claimed |
| CN-106518765-A | Synthetic method of pesticide intermediate pyrazole-4-ethyl formate | 上海微巨实业有限公司 | 2017-03-22 | — | — | CN | claimed |
| US-9466827-B2 | Secondary battery | NEC CORPORATION (JP) | 2016-10-11 | — | — | US | claimed |
| US-6972331-B2 | Carboxy pyrrole, process of preparing and use as precursor | BIOCRYST PHARMACEUTICALS, INC. (US) | 2005-12-06 | — | — | US | claimed |
| US-20040214840-A1 | Carboxy pyrrole, process of preparing and use as precursor | BIOCRYST PHARMACEUTICALS, INC. | 2004-10-28 | — | — | US | claimed |
| EP-0333661-B1 | Process for the preparation of a pyrole derivative | CIBA GEIGY AG (CH) | 1994-04-27 | — | — | EP | claimed |
| US-5281718-A | Reacting in one pot reaction 2,2-difluorobenzodioxole with an organometal compound or metal to form 4-metallo-2,2-difluorobenzodioxole, reacting with unsaturated nitrile, then with isocyanide | CIBA-GEIGY CORPORATION (US) | 1994-01-25 | — | — | US | claimed |
| JP-60181087-A | — | — | None | — | — | JP | disclosed |
| US-3925385-A | 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines | VIRATEK, INC., A CORP. OF DE. | 1975-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214840-A1 | Carboxy pyrrole, process of preparing and use as precursor | PNPO, PNP, FTO | CYP2C9 252/4885ALDH1A1 1840/4885TSHR 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.